A detailed history of Saxon Interests, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Saxon Interests, Inc. holds 27,376 shares of AVXL stock, worth $156,590. This represents 0.07% of its overall portfolio holdings.

Number of Shares
27,376
Previous 26,699 2.54%
Holding current value
$156,590
Previous $112,000 38.39%
% of portfolio
0.07%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$4.11 - $7.04 $2,782 - $4,766
677 Added 2.54%
27,376 $155,000
Q1 2024

Apr 18, 2024

BUY
$4.55 - $6.75 $121,480 - $180,218
26,699 New
26,699 $135,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $446M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Saxon Interests, Inc. Portfolio

Follow Saxon Interests, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saxon Interests, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Saxon Interests, Inc. with notifications on news.